Saturday 17 October 2026
Export GNTA’s income statement to Excel — free account
Genenta Science S.p.A. Unsponsored ADR
GNTA Healthcare Biotechnology
0.68
0.01
+1.49%
Follow GNTA
| Dec '25 | Jun '25 | Dec '24 | Jun '24 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | 0.00% |
+7 more TTM periods Free account |
|
| 0.00% | 0.00% | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(23.02) | (27.39) | (29.40) | (30.48) | |
Capital Expenditures |
(0.02) | (0.03) | (0.04) | (0.06) | |
| Other line items | |||||
Cash ROIC |
(35.33%) | (64.61%) | (107.99%) | (83.94%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | 0.00% | — | 0.00% | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.71 | 3.21 | 0.92 | 0.67 | |
Capex/Depreciation |
(0.20) | (0.23) | (0.25) | (0.59) | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates